Katsutani N, Shionoya H
Department of Drug Safety Research, Eisai Co., Ltd, Takehaya, Gifu, Japan.
Int J Immunopharmacol. 1992 May;14(4):673-9. doi: 10.1016/0192-0561(92)90130-d.
The drug-induced graft vs host reaction (GVHR) hypothesis requires, as its first step, specific T-cell immune responses to the drug-modified self. Procainamide, isoniazid and hydralazine are known to provoke various allergic reactions including GVHR-like adverse effects in man. We now report that drug-specific immune responses can easily be induced by these drugs in guinea-pigs. Twenty-five milligrams of each of these drugs and penicillin G, which is known to make covalent bonds with proteins and to also induce drug-specific immune responses, were mixed with complete Freund's adjuvant (CFA) and subcutaneously (s.c.) injected twice at an interval of 2 weeks into female Hartley guinea-pigs. The antibodies to these drugs were assessed by means of an enzyme-linked immunosorbent assay (ELISA). Two weeks after the last injection, all animals treated with isoniazid, hydralazine and penicillin G produced high titers of antibodies to these drugs. Antibodies to procainamide were also detected, although their antibody titers were low. The specificity of the antibodies produced were tested by the inhibition of ELISA and concentration-dependent inhibition was observed. Delayed type hypersensitivity (DTH) reactions were also observed in the animals treated with procainamide, isoniazid and hydralazine 2 weeks after the last injection. These results suggest that the allergic reactions observed in clinical use are related to the inducing potential of drug-specific immune responses in an animal system. Therefore, immunization of guinea-pigs with test drugs and CFA may give useful information for predicting the occurrence of allergic reactions in man.
药物诱导的移植物抗宿主反应(GVHR)假说的第一步要求对药物修饰的自身产生特异性T细胞免疫反应。已知普鲁卡因胺、异烟肼和肼屈嗪会引发各种过敏反应,包括在人类中出现类似GVHR的不良反应。我们现在报告,这些药物在豚鼠中很容易诱导出药物特异性免疫反应。将这三种药物各25毫克以及已知能与蛋白质形成共价键并诱导药物特异性免疫反应的青霉素G与完全弗氏佐剂(CFA)混合,每隔2周皮下注射雌性Hartley豚鼠两次。通过酶联免疫吸附测定(ELISA)评估针对这些药物的抗体。最后一次注射两周后,所有用异烟肼、肼屈嗪和青霉素G处理的动物都产生了高滴度的针对这些药物的抗体。也检测到了针对普鲁卡因胺的抗体,尽管其抗体滴度较低。通过ELISA抑制试验检测所产生抗体的特异性,观察到浓度依赖性抑制。在最后一次注射两周后,用普鲁卡因胺、异烟肼和肼屈嗪处理的动物也出现了迟发型超敏反应(DTH)。这些结果表明,临床使用中观察到的过敏反应与动物系统中药物特异性免疫反应的诱导潜力有关。因此,用受试药物和CFA免疫豚鼠可能为预测人类过敏反应的发生提供有用信息。